Clinical trial NCT05617560: Hospital@Home: Telemedical Care After Inpatient Hospital Stay
Official title: Hospital@Home: Telemedical Care After Inpatient Hospital Stay
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Telemedicine
Keywords: Medgate
Patient transfer path
Telemedical care
Telephone consultation
Videocall consultation
ergebnisorientiertes Patientenassessment - AcuteCare (ePA-AC)
Patient-Reported Experience Measures Survey (PREMS)
Patient Reported Outcome Measures Survey (PROMS)
Lead sponsor: University Hospital, Basel, Switzerland
Sponsor class: OTHER
Collaborators: name: Innosuisse - Swiss Innovation Agency
First posted: 2022-11-15
Enrollment: 234
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: investigator-initiated, prospective, single-center clinical intervention study
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures. Telemedical support will be executed by Medgate who will refer the patients to their GPs after the telemedical consultations are completed. Inclusion criteria is the need for short time follow up procedures that can be handled by telemedicine. Throughout the study, patient and stakeholder satisfaction will be measured and data-based methods will be developed to assess patient transfer success. Overall, new information flow and communication between the stakeholders (hospital, telemedicine and general practitioners) are defined and tested. The Hospital@Home pilot study is intended to become a flagship project for new healthcare models.

Detailed description: This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures.

The following study procedures are depicted:

Visit 1 (screening): Patients provide the name of their GP, the means of transport that they usually take to him, demographic data, past medical history and current medications.

The study team contacts the GP afterwards by phone to get his/her consent. The study team informs Medgate about the participant and the procedure. Next to that it will link Medgate technically to the case of the patient that Medgate can see the patient's documentation in the University Hospital Basel (USB) -ePortal.

Visit 2 (transfer): Before leaving the hospital, the participant will be instructed by a member of the study team on how and when to fill out the questionnaires. At this time, the participant and the USB physician will answer the first one. After Medgate has received the information from USB that the patient has been included in the study and has left the hospital, the patient will be contacted by Medgate and the appointment for the first teleconsultation will be made according to information from USB. The patient will be called by Medgate physician at the agreed time and the teleconsultation will be performed. Depending on the patient's condition and health status, further appointments are scheduled. The patient has the possibility to contact Medgate at any time (24/7) in case of an urgent medical matter. The patient receives the physician's recommendations in written form after each teleconsultation as their treatment plan via app or e-mail.

Visit 3...x (telecare): In advance of the first consultation via Medgate, the Medgate physician will log in into the USB-ePortal to get all important medical information about the patient. After that consultation the patient and the Medgate physician will answer a questionnaire. Depending on the clinical condition, health status and from this resulted procedure, the participant will be contacted several times. After the last consultation the Medgate physician will answer a questionnaire and will refer the patient back to the GP. The documentation will be sent to the GP and the USB. The GP will get a questionnaire as well.

Visit 4 (follow-up): On day x after the last consultation via Medgate the GP and the participant will answer the last questionnaire.

Eligibility criteria: Inclusion Criteria:

* Written informed consent as documented by signature from the patient
* Planned hospital discharge
* Intended follow-up care, that is manageable with telemedicine

Exclusion Criteria:

* Significant mental or cognitive impairment
* Unable or not willing to sign informed consent
* Unable to understand German
* No possibility of telecommunication or use of such (app or phone)

Primary outcomes:
measure: Change in PROMS (patient-reported outcome measures survey)
timeFrame: From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks
measure: PREMS (patient reported experience measure survey) conducted by patients
timeFrame: From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks
measure: PREMS (patient reported experience measure survey) conducted by physicians
timeFrame: From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks
Secondary outcomes:
Other outcomes:
measure: Change in self-care index (Selbstpflegeindex (SPI))
timeFrame: From Visit 1 (Screening) up to Visit 3 (Telecare), approx. 1 week
measure: Change in result-oriented patient assessment (ergebnisorientiertes Patientenassessment - AcuteCare (ePA-AC))
timeFrame: From Visit 1 (Screening) up to Visit 2 (Transfer) assessed daily at the hospital, approx. 1 week
Locations:
city: Basel
country: Switzerland
facility: University Hospital Basel, Division of Internal Medicine
Study officials:
affiliation: University Hospital Basel, Division of Internal Medicine
name: Jens Eckstein, Prof. Dr. med.
role: PRINCIPAL_INVESTIGATOR
References: